Abstract
Background
Continuous glucose monitoring (CGM) for diabetes combines noninvasive glucose biosensors, continuous monitoring, cloud computing, and analytics to connect and simulate a hospital setting in a person’s home. CGM systems inspired analytics methods to measure glycemic variability (GV), but existing GV analytics methods disregard glucose trends and patterns; hence, they fail to capture entire temporal patterns and do not provide granular insights about glucose fluctuations.
Objective
This study aimed to propose a machine learning–based framework for blood glucose fluctuation pattern recognition, which enables a more comprehensive representation of GV profiles that could present detailed fluctuation information, be easily understood by clinicians, and provide insights about patient groups based on time in blood fluctuation patterns.
Methods
Overall, 1.5 million measurements from 126 patients in the United Kingdom with type 1 diabetes mellitus (T1DM) were collected, and prevalent blood fluctuation patterns were extracted using dynamic time warping. The patterns were further validated in 225 patients in the United States with T1DM. Hierarchical clustering was then applied on time in patterns to form 4 clusters of patients. Patient groups were compared using statistical analysis.
Results
In total, 6 patterns depicting distinctive glucose levels and trends were identified and validated, based on which 4 GV profiles of patients with T1DM were found. They were significantly different in terms of glycemic statuses such as diabetes duration (P=.04), glycated hemoglobin level (P<.001), and time in range (P<.001) and thus had different management needs.
Conclusions
The proposed method can analytically extract existing blood fluctuation patterns from CGM data. Thus, time in patterns can capture a rich view of patients’ GV profile. Its conceptual resemblance with time in range, along with rich blood fluctuation details, makes it more scalable, accessible, and informative to clinicians.
Reference57 articles.
1. IDF Diabetes Atlas 10th editionInternational Diabetes Federation20212022-09-26https://diabetesatlas.org/atlas/tenth-edition/
2. Global health estimates: Leading causes of death. Cause-specific mortality, 2000–2019World Health Organization20202022-09-26https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death
3. Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
4. ReddyNVermaNDunganKMonitoring technologies- continuous glucose monitoring, mobile technology, biomarkers of glycemic controlEndotext202008162022-09-26https://www.ncbi.nlm.nih.gov/books/NBK279046/
5. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018